Wedge Capital Management L L P Amicus Therapeutics, Inc. Transaction History
Wedge Capital Management L L P
- $5.35 Billion
- Q2 2025
A detailed history of Wedge Capital Management L L P transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Wedge Capital Management L L P holds 144,710 shares of FOLD stock, worth $982,580. This represents 0.02% of its overall portfolio holdings.
Number of Shares
144,710
Previous 143,778
0.65%
Holding current value
$982,580
Previous $1.21 Million
31.6%
% of portfolio
0.02%
Previous 0.02%
Shares
10 transactions
Others Institutions Holding FOLD
# of Institutions
309Shares Held
323MCall Options Held
378KPut Options Held
575K-
Wellington Management Group LLP Boston, MA29.2MShares$198 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.1MShares$197 Million0.0% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$165 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY21.5MShares$146 Million7.33% of portfolio
-
Avoro Capital Advisors LLC New York, NY20.5MShares$139 Million2.71% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $1.9B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...